Arg1 |
Arginase-1 |
BMDMs |
Bone marrow-derived macrophages |
BSYS |
Bu Shen Yi Sui capsule |
CCL2 |
C-C motif chemokine ligand 2 |
CCL3 |
C-C motif chemokine ligand 3 |
CD74 |
Major histocompatibility complex, class II invariant chain |
C/EBP-α |
CCAAT/enhancer-binding protein-α |
CNS |
Central nervous system |
DR |
Diabetic retinopathy |
EAE |
Experimental autoimmune encephalomyelitis |
ERG |
Electroretinography GCL ganglion cell layer |
Flot1 |
Flottilin-1 |
Gapdh |
Glyceraldehyde 3-phosphate dehydrogenase |
GS |
Glutamine synthetase |
IFN-γ |
Interferon gamma |
IL-1β |
Interleukin-1β |
IL-10 |
Interleukin-10 |
ILM |
Inner limiting membrane |
INL |
Inner nuclear layer |
IPL |
Inner plexiform layer |
MHC-II |
Major histocompatibility complex class II molecule |
miR-124 |
MicroRNA-124 |
miR-inh |
MicroRNA-124 inhibitor |
NVU |
Neurovascular unit |
OLM |
Outer limiting membrane |
ONL |
Outer nuclear layer |
OPL |
Outer plexiform layer |
PD |
Photo-oxidative damage |
PKD |
Polycystic kidney disease |
PU.1 |
Protein binding U box |
SCI |
Spinal cord injury |
SD |
Sprague Dawley |
Spi1 |
Salmonella Pathogenicity Island 1 (gene name of PU.1) |
TNF-α |
Tumor necrosis factor-α |
TNFR |
TNF receptor |